Pulmatrix +6% premarket on NasoCalm deal for COVID-19 [Seeking Alpha]
Pulmatrix, Inc. (PULM)
Last pulmatrix, inc. earnings: 8/5 09:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.pulmatrix.com
Company Research
Source: Seeking Alpha
Healthcare|On the MovePulmatrix +6% premarket on NasoCalm deal for COVID-19Apr. 16, 2020 8:57 AM ETPulmatrix, Inc. (PULM)Mamta MayaniPulmatrix (NASDAQ:enteredUnder the terms of the agreement, Pulmatrix will out-license intellectual property of NasoCalm (PUR 003 and PUR 006) for worldwide distribution, commercialization and marketing with escalating royalties of 7% in 2020, 14% in 2021 and 17% over the remaining life of the agreement.The Licensed Products include OTC nasal delivery to potentially reduce the pathogenic risk and transmissibility of contagions, including with respect to COVID-19.Pulmatrix has the right to terminate the Agreement in the event that Sensory Cloud fails to meet certain milestones related to the nasal prophylactic and anti-contagion product.In addition, PULM shall be entitled to receive a milestone payment of $1M following the achievement of aggregate net sales of all Licensed Products of $20M.Shares are upSee all stocks on the move »Now read:ThermoGenesis on
Show less
Read more
Impact Snapshot
Event Time:
PULM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PULM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PULM alerts
High impacting Pulmatrix, Inc. news events
Weekly update
A roundup of the hottest topics
PULM
News
- Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Pulmatrix (NASDAQ:PULM) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Pulmatrix (NASDAQ:PULM) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation AssetsPR Newswire
PULM
Sec Filings
- 10/16/25 - Form 10-Q
- 10/16/25 - Form 8-K
- PULM's page on the SEC website